Canada
I lead healthcare and life‑sciences organizations through growth, transformation, and complexity across Africa, the Middle East, Asia, Europe, and the Americas. My career spans end‑to‑end P&L leadership, multi‑country operations, and large‑scale transformation across pharmaceuticals, biologics, vaccines, APIs, devices, critical care, and diversified industrial portfolios. As Group CEO & Global Head, I oversaw multi‑billion‑dollar healthcare and biologics portfolios, leading strategy, commercial execution, manufacturing, supply chains, regulatory governance, and market access across 22+ countries. My flagship mandate—Dei BioPharma Ltd. (Uganda)—is a biologics and vaccines enterprise delivering life‑saving therapies for global markets. My leadership philosophy is Performance with Purpose: building organizations that deliver sustainable results while remaining accountable to patients, communities, and stakeholders. I believe leadership is a responsibility to create institutions that endure, perform, and contribute meaningfully. Career Highlights • Led global strategy, commercial execution, and manufacturing/supply chain operations for complex healthcare portfolios. • Directed governance, turnarounds, growth acceleration, and portfolio optimization initiatives. • Managed independent CEOs and senior leadership teams across geographies. • Partnered with global healthcare leaders including Abbott, Pfizer (BioNTech), Sanofi‑Aventis, Alcon, Novo Nordisk, AstraZeneca, Boston Scientific, Beckman Coulter, Dr. Reddy’s, Zydus, Sun Pharma, Cipla, Alkem, BSV and others. • Delivered multi‑country expansion, operational scale‑up, and transformation across emerging markets. I currently advise on Africa‑focused biotech, pharmaceutical manufacturing, and healthcare innovation, including the IMPI Biotech City (Zimbabwe), working with Ministries of Health, investment agencies, and regional stakeholders under AfCFTA‑aligned local manufacturing programs. At heart, I am a lifelong learner and mentor committed to developing leaders and building organizations that combine operational excellence with integrity and purpose. Education: MBA (IIM Calcutta) | CAFS (USA) | MBIM (UK) Awards: Multiple merit awards from Abbott Foundation, Chicago, USA
. Lead strategic advisory for Africa’s first multibillion‑dollar Biotechnopolis, shaping biotech, pharma manufacturing, vaccines, diagnostics, and healthcare innovation ecosystems. . Drive market access, regulatory navigation, and portfolio optimisation across emerging markets, working with Ministries of Health, investment agencies, and regional authorities. .Design pricing, access, and supply‑chain strategies aligned with AfCFTA‑driven pharmaceutical manufacturing and local production initiatives. .Shape manufacturing footprint strategy, including site selection, contract manufacturing partnerships, and technology‑transfer pathways across Africa. .Strengthen route‑to‑market models (distributors, institutional/tender, regional platforms such as AMSEPS) to deliver sustainable growth in regulated markets. .Guide cross‑sector collaborations spanning biologics, vaccines, AI‑enabled healthcare, clinical research, and supply‑chain optimisation. .Align strategy with execution across process, data, technology, product, patient, infrastructure, and market pillars to build a globally competitive Africa Biotechnopolis hub anchored in Zimbabwe, with Africa‑wide scope.
. Led global strategy, commercial execution, and operational performance across a diversified healthcare and industrial portfolio spanning Africa, Middle East, Asia, CIS, Europe, and the Americas. . Managed multi‑million‑dollar biologics, vaccines, and healthcare portfolios, delivering 40% growth in institutional and tender business. . Oversaw manufacturing, R&D, regulatory, supply chain, and market access functions across 22 African countries. . Built and governed five manufacturing partnerships across Africa and Asia, strengthening regional production capacity. . Directed turnaround, growth, and portfolio optimisation initiatives across multiple business units. . Provided governance oversight for independent CEOs and senior leadership teams across geographies. . Flagship: Led Dei BioPharma Ltd., a multibillion‑dollar biologics and vaccines enterprise delivering life‑saving therapies.
. Held full P&L leadership across Africa, UK, China, and India, overseeing commercial, manufacturing, regulatory, and distribution operations. . Led multi‑country product introduction, market access, and commercialisation strategies across Southeast Asia and Africa. . Built and managed distributor networks across Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines. . Strengthened institutional/tender business and government engagement across regulated markets. . Directed cross‑border manufacturing networks, regulatory compliance, and market expansion initiatives. . Represented and partnered with Fortune 100 healthcare MNCs on commercial, regulatory, and supply‑chain programs. . Built scalable operating models and leadership capability across diverse geographies.
. Led multi‑country commercial and clinical engagement across South Asia and Southeast Asia. . Directed national sales, marketing strategy, and specialty portfolio expansion across multiple therapeutic areas. . Built and scaled pan‑India commercial operations, strengthening brand presence and market share. . Managed cross‑functional teams for specialty portfolios and clinical programs. . Established new facilities and expanded manufacturing capabilities in OSD and Ophthalmology. . Strengthened institutional business, key account management, and market expansion.
. Progressed from Medical Officer to Regional Sales Leader across leading global and Indian pharmaceutical organisations. . Built foundational expertise in healthcare sales, key account management, and market development. . Developed early leadership capability in commercial operations and team management.